Literature DB >> 23211845

Reasons for participation and nonparticipation in colorectal cancer screening: a randomized trial of colonoscopy and CT colonography.

Thomas R de Wijkerslooth1, Margriet C de Haan, Esther M Stoop, Patrick M Bossuyt, Maarten Thomeer, Monique E van Leerdam, Marie-Louise Essink-Bot, Paul Fockens, Ernst J Kuipers, Jaap Stoker, Evelien Dekker.   

Abstract

OBJECTIVES: We compared reported reasons for participation and nonparticipation in colorectal cancer (CRC) screening between colonoscopy and computed tomographic (CT) colonography in a randomized controlled trial.
METHODS: We randomly invited 8,844 people for screening by colonoscopy or CT colonography. On a questionnaire, invitees indicated reasons for participation or nonparticipation and indicated the most decisive reason.
RESULTS: The most frequently cited reasons to accept screening were early detection of precursor lesions and CRC, and contribution to science. The most frequently cited reasons to decline were the unpleasantness of the examination, the inconvenience of the preparation, a lack of symptoms, and "no time/too much effort." Among colonoscopy nonparticipants, elderly invitees cited inconvenience less often, and absence of symptoms more often, than did the group overall. The reason reported most frequently as the most decisive reason not to participate was the unpleasantness of the examination among colonoscopy nonparticipants, and "no time/too much effort" and lack of symptoms among CT colonography nonparticipants.
CONCLUSIONS: In light of these results, future screening programs could tailor the information provided to invitees.

Entities:  

Mesh:

Year:  2012        PMID: 23211845     DOI: 10.1038/ajg.2012.140

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  17 in total

1.  Patients' experience of screening CT colonography with reduced and full bowel preparation in a randomised trial.

Authors:  Lapo Sali; Leonardo Ventura; Grazia Grazzini; Alessandra Borgheresi; Silvia Delsanto; Massimo Falchini; Beatrice Mallardi; Paola Mantellini; Stefano Milani; Stefano Pallanti; Marco Zappa; Mario Mascalchi
Journal:  Eur Radiol       Date:  2018-11-06       Impact factor: 5.315

2.  Diagnostic Accuracy of Fecal Immunochemical Test in Patients at Increased Risk for Colorectal Cancer: A Meta-analysis.

Authors:  Anastasia Katsoula; Paschalis Paschos; Anna-Bettina Haidich; Apostolos Tsapas; Olga Giouleme
Journal:  JAMA Intern Med       Date:  2017-08-01       Impact factor: 21.873

3.  Reasons for and reservations about research participation in acutely injured adults.

Authors:  Elliane Irani; Therese S Richmond
Journal:  J Nurs Scholarsh       Date:  2015-01-19       Impact factor: 3.176

Review 4.  Quality indicators for colonoscopy: Current insights and caveats.

Authors:  Hendrikus Jm Pullens; Peter D Siersema
Journal:  World J Gastrointest Endosc       Date:  2014-12-16

5.  Findings from the first colorectal cancer screening among 103 542 individuals in Vietnam with systematic review of colorectal cancer screening programs in Asia-Pacific region.

Authors:  Chi Thi-Du Tran; Mai Vu-Tuyet Nguyen; Mo Thi Tran; Thuy Thi-Van Tuong; Quang Hong Tran; Linh Cu Le; Huong Thi-Thu Pham; Nam Chi Bui; Hien Huy Vu; Tu Thi-Cam Nguyen; Phuong Que Ta; Hien Thi-Thu Ha; Dung Tuan Trinh; Hanh Thi-My Bui; Dien Quang Trinh; Khanh Van Nguyen; Song Huu Le; Khien Van Vu; Thuan Van Tran; Huong Thi-Thanh Tran; Martha J Shrubsole; Fei Ye; Qiuyin Cai; Wei Zheng; Paolo Boffetta; Xiao-Ou Shu; Hung N Luu
Journal:  Jpn J Clin Oncol       Date:  2022-07-08       Impact factor: 2.925

6.  Comparison of the participation rate between CT colonography and colonoscopy in screening population: a systematic review and meta-analysis of randomized controlled trials.

Authors:  He Zhu; Fudong Li; Ke Tao; Jing Wang; Carissa Scurlock; Xiaofei Zhang; Hong Xu
Journal:  Br J Radiol       Date:  2019-11-01       Impact factor: 3.039

7.  Clinical indications for computed tomographic colonography: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline.

Authors:  Cristiano Spada; Jaap Stoker; Onofre Alarcon; Federico Barbaro; Davide Bellini; Michael Bretthauer; Margriet C De Haan; Jean-Marc Dumonceau; Monika Ferlitsch; Steve Halligan; Emma Helbren; Mikael Hellstrom; Ernst J Kuipers; Philippe Lefere; Thomas Mang; Emanuele Neri; Lucio Petruzziello; Andrew Plumb; Daniele Regge; Stuart A Taylor; Cesare Hassan; Andrea Laghi
Journal:  Eur Radiol       Date:  2015-02       Impact factor: 5.315

8.  Blood RNA biomarker panel detects both left- and right-sided colorectal neoplasms: a case-control study.

Authors:  Samuel Chao; Jay Ying; Gailina Liew; Wayne Marshall; Choong-Chin Liew; Robert Burakoff
Journal:  J Exp Clin Cancer Res       Date:  2013-07-23

9.  Using a hypothetical scenario to assess public preferences for colorectal surveillance following screening-detected, intermediate-risk adenomas: annual home-based stool test vs. triennial colonoscopy.

Authors:  Bernardette Bonello; Alex Ghanouni; Harriet L Bowyer; Eilidh MacRae; Wendy Atkin; Stephen P Halloran; Jane Wardle; Christian von Wagner
Journal:  BMC Gastroenterol       Date:  2016-09-13       Impact factor: 3.067

10.  Detection of cancers and advanced adenomas in asymptomatic participants in colorectal cancer screening: a cross-sectional study.

Authors:  Anna Lisa Schult; Edoardo Botteri; Geir Hoff; Kristin R Randel; Eirin Dalén; Sigrun Losada Eskeland; Øyvind Holme; Thomas de Lange
Journal:  BMJ Open       Date:  2021-07-01       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.